Novel PSMA-Targeting Radionuclide Peptidomimetics for Treating Prostate Cancer.
Sign Up to like & getrecommendations! Published in 2022 at "ACS medicinal chemistry letters"
DOI: 10.1021/acsmedchemlett.2c00510
Abstract: Prostate cancer is the third-most commonly diagnosed cancer and is one of the leading causes of cancer-related deaths in men worldwide. Although an armamentarium of approved drugs exists, treatment options become severely limited when resistance… read more here.
Keywords: prostate cancer; novel psma; targeting radionuclide; psma targeting ... See more keywords